| Real-time Estimate Cboe BZX Other stock markets | 5-day change | 1st Jan Change | ||
| 15.88 USD | -0.16% |  | -1.18% | -39.03% |
| 06-24 | Equity Markets Close Mixed as Investors Await Key Earnings | MT |
| 06-24 | Equity Markets Close Mixed as Investors Await Week's Key Earnings | MT |
This article is reserved for members
Already a member?
Log In
Not a member ?
Free registration
Latest news about Walgreens Boots Alliance, Inc.
| Equity Markets Close Mixed as Investors Await Key Earnings | MT | |
| Equity Markets Close Mixed as Investors Await Week's Key Earnings | MT | |
| US Equities Markets End Mixed Monday as Traders Await Key Corporate Earnings | MT | |
| Equity Markets Mixed as Investors Await Week's Key Earnings | MT | |
| Walgreens Boots Alliance Fiscal Q3 Unlikely to Impact Stock, UBS Says | MT | |
| Equity Markets Mixed as Investors Await Week's Key Earnings | MT | |
| UBS Cuts Price Target on Walgreens Boots Alliance to $17 From $22, Maintains Neutral Rating | MT | |
| Key week for monetary policy |  | |
| Futures Mostly Up Pre-Bell as Investors Prepare for Key Inflation Report; Asia Down, Europe Rises | MT | |
| Barclays Adjusts Price Target on Walgreens Boots Alliance to $15 From $21 | MT | |
| ANALYST RECOMMENDATIONS : Accenture, Walgreens Boots Alliance, Ge Vernova, Pepsico, Britvic... | | |
| Amazon Pharmacy expands $5 monthly subscription to Medicare patients | RE | |
| CVS Store-Brand Medications Face Quality Concerns and Higher Recall Rates | MT | |
| Global markets live: ABB, Roche, Microsoft, Apple, Tesla... | | |
| Walgreens Reportedly Shelves Plans for Boots IPO as Sale Talks Continue | CI | |
| Top law firms in US opioid lawsuits to get hundreds of millions in fees | RE | |
| CityMD Agrees to $12 Million to Pay Department of Justice Over Alleged Covid-19 Payments Violation | DJ | |
| CityMD Agrees to $12 Million to Pay Department of Justice Over Alleged Covid-19 Payments Violation -- Update | DJ | |
| Sector Update: Health Care Stocks Higher Late Afternoon | MT | |
| Sector Update: Health Care | MT | |
| Walgreens Shelves Boots IPO Plans, Explores Other Options | MT | |
| Walgreens Shelves Boots IPO Plans, Explores Other Options | MT | |
| Walgreens shelves plans for Boots IPO, Bloomberg News reports | RE | |
| Walgreens to Shelve Boots IPO Plans as Sale Talks Continue, Bloomberg Says | MT | |
| Leerink Adjusts Price Target on Walgreens Boots Alliance to $17 From $22 | MT |
Chart Walgreens Boots Alliance, Inc.
More charts
Company Profile
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows:- retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet;- wholesale distribution (8.1%).The remaining sales (4.7%) are from the healthcareNet sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).
Sector
Drug Retailers
Calendar
27/06/2024 - Q3 2024 Earnings Release
More about the company
Income Statement Evolution
More financial data
Analysis / Opinion
More Strategies
Ratings for Walgreens Boots Alliance, Inc.
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
15.91USD
Average target price
21.52USD
Spread / Average Target
+35.26%
Consensus
EPS Revisions
Estimates Revisions
Quarterly earnings - Rate of surprise
Company calendar
Sector Other Drug Retailers
| 1st Jan change | Capi. | |
|---|---|---|
WALGREENS BOOTS ALLIANCE, INC. | -39.03% | 13.73B |
JD HEALTH INTERNATIONAL INC. | -42.20% | 9.46B |
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED | -21.70% | 7.11B |
| -7.79% | 5.88B | |
CORPORATIVO FRAGUA, S.A.B. DE C.V. | +78.71% | 4.79B |
NAHDI MEDICAL COMPANY | -4.09% | 4.54B |
CLICKS GROUP LIMITED | +3.97% | 4.44B |
YIFENG PHARMACY CHAIN CO., LTD. | -21.90% | 4.35B |
WELCIA HOLDINGS CO., LTD. | -16.95% | 2.64B |
REDCARE PHARMACY NV | -9.19% | 2.63B |
Other Drug Retailers
- Stock Market
- Equities
- WBA Stock
- News Walgreens Boots Alliance, Inc.
- UBS Cuts Price Target on Walgreens Boots Alliance to $17 From $22, Maintains Neutral Rating
